Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Development of in vitro susceptibility testing criteria and quality control parameters
1989 • 391 citations
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination
1987 • 34 citations
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing
1988 • 31 citations
Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria
1987 • 24 citations
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination
1988 • 24 citations
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control
1988 • 16 citations
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid
1987 • 16 citations
Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria
1989 • 16 citations
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin
1987 • 11 citations
In vitro antimicrobial activity of tigemonam, a new orally administered monobactam
1988 • 11 citations
Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards
1989 • 9 citations
Quality control limits for microdilution susceptibility tests with norfloxacin
1987 • 4 citations
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101
1988 • 4 citations
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods
1987 • 2 citations